As of 2026-06-06, the EV/EBITDA ratio of Genomic Vision SA (GV.PA) is -0.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GV.PA's latest enterprise value is 1.66 mil EUR. GV.PA's TTM EBITDA according to its financial statements is -7.39 mil EUR. Dividing these 2 quantities gives us the above GV.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.6x - 9.1x | 7.7x |
| Forward P/E multiples | 6.7x - 7.4x | 7.2x |
| Fair Price | (0.15) - (0.14) | (0.15) |
| Upside | -8299.5% - -8086.8% | -8161.3% |
| Date | EV/EBITDA |